Page last updated: 2024-08-23

lovastatin and Constriction, Pathological

lovastatin has been researched along with Constriction, Pathological in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavero, PG; Hartzler, GO; Kacich, RL; Kahn, J; Ligon, R; Maddex, C; McCallister, BD; O'Keefe, JH; Stone, GW1
Boccuzzi, SJ; Ghazzal, ZM; King, SB; Klein, L; Kosinski, AS; Waksman, R; Weintraub, WS1

Trials

1 trial(s) available for lovastatin and Constriction, Pathological

ArticleYear
Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    The American journal of cardiology, 1996, Mar-15, Volume: 77, Issue:8

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Probucol; Recurrence

1996

Other Studies

1 other study(ies) available for lovastatin and Constriction, Pathological

ArticleYear
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
    The American journal of cardiology, 1996, Jul-15, Volume: 78, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Humans; Lovastatin; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome

1996